The hottest research from various peer-reviewed journals – handpicked weekly by the ACC.org Editorial Board led by Kim A. Eagle, MD, MACC.
'Real-World' Prolonged DAPT Use Associated With Reduced Benefits, Greater Harm: NCDR Study
Prolonged use of DAPT following PCI may be associated with reduced benefits and greater harms in "real-world" clinical practice vs. the DAPT Study, according to a recent study using data from ACC's CathPCI Registry. The study by Neel M. Butala, MD, MBA, et al., was published in Circulation.
ACC EP Device Implant Registry: ICD Implantations Down Among Patients Not Meeting NCD Criteria After DOJ Investigation
There was a rapid reduction in ICDs placed among patients with a diagnosis of a recent acute myocardial infarction (AMI) or recent heart failure (HF) after a Department of Justice (DOJ) investigation of the use of ICDs, according to a study published in the Journal of Cardiac Failure.
STS/ACC TVT Registry: Patient-Reported vs. Physician-Estimated Symptoms in TAVR
Physicians do a poor job of estimating symptoms and functional status in patients with severe aortic stenosis undergoing TAVR, emphasizing the importance of collecting patient-reported health status, according to a study published in the European Heart Journal: Quality of Care & Clinical Outcomes.
AXIOMATIC-TKR: Factor XIa Inhibitor Milvexian For VTE Prevention
The novel factor XIa inhibitor milvexian is effective in the prevention of venous thromboembolism (VTE) in patients undergoing knee arthroplasty, according to a study presented at AHA 2021 and published in the New England Journal of Medicine.
Keywords: ACC Publications, Cardiology Magazine, COVID-19 Vaccines, Drug-Eluting Stents, Platelet Aggregation Inhibitors, Anticoagulants, Azithromycin, Enoxaparin, Factor XIa, Hydroxychloroquine, Venous Thromboembolism, Warfarin, Percutaneous Coronary Intervention, Centers for Medicare and Medicaid Services, U.S., Incidence, Accidental Falls, Arm, Arthroplasty, Replacement, Knee, Atrial Fibrillation, Benchmarking, COVID-19, COVID-19 Testing, Catalytic Domain, Foramen Ovale, Patent, Half-Life, Hospital Mortality, Myocarditis, Noncommunicable Diseases, Quality Improvement, Reading, Saliva, Medicare, Myocardial Infarction, Thrombosis, Registries, Primary Prevention, Venous Thrombosis, Nasopharynx, Hypersensitivity, Heart Failure, Long QT Syndrome, Budesonide, Hospitals, Stroke, Coronary Artery Bypass
< Back to Listings